Search filters

List of works by David McDonnell

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

scientific article published on 27 May 2015

A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects

scientific article published on 01 May 2019

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future

scientific article published on 05 September 2019

An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia.

scientific article published in May 2008

Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine-Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study

scientific article published on 30 July 2018

Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program.

scientific article published in January 2008

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine.

scientific article

D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia.

scientific article published on 18 April 2007

Dose correspondence between olanzapine long-acting injection and oral olanzapine: recommendations for switching

scientific article published on 01 January 2011

Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia ⬇️

scientific article published on February 15, 2011

Effect of Food on the Pharmacokinetics of a Combination of Olanzapine and Samidorphan

scientific article published on 28 March 2019

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study

scientific article

F232. A PHASE 3 STUDY TO DETERMINE THE ANTIPSYCHOTIC EFFICACY AND SAFETY OF ALKS 3831 IN ADULT PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA.

scientific article

Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.

scientific article published on January 2014

Long-Term Safety and Durability of Effect With a Combination of Olanzapine and Samidorphan in Patients With Schizophrenia: Results From a 1-Year Open-Label Extension Study

scientific article published on 12 May 2020

Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study

scientific article

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

scientific article published on 01 May 2019

Pharmacokinetics and Short-term Safety of ALKS 3831, a Fixed-dose Combination of Olanzapine and Samidorphan, in Adult Subjects with Schizophrenia

scientific article published on 20 October 2018

Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.

scientific article published on 23 August 2012

S226. A STUDY COMPARING WEIGHT GAIN FROM ALKS 3831 TO OLANZAPINE IN EARLY-ILLNESS YOUNG ADULTS WITH SCHIZOPHRENIFORM, SCHIZOPHRENIA, OR BIPOLAR I DISORDER.

scientific article

Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis.

scientific article published on 4 March 2014

Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.

scientific article published on 31 October 2013

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons ⬇️

scientific article published on May 4, 2012

Within-drug benefit-risk evaluation of olanzapine long-acting injection at one and two years of treatment

scientific article

Paulina is supported by:

About Paulina

Help